Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults
Spencer, Sarah, Chung, Jessie R., Belongia, Edward A., Sundaram, Maria, Meece, Jennifer, Coleman, Laura A., Zimmerman, Richard, Nowalk, Mary Patricia, Moehling, Krissy K., Ross, Ted, Carter, Chalise E., Shay, David, Levine, Min, Liepkalns, Justine, Kim, Jin Hyang, Sambhara, Suryaprakash, Thompson, Mark and Flannery, Brendan (2021) Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults. Influenza and other respiratory viruses. ISSN 1750-2659; 1750-2640
Abstract
Individuals with type 2 diabetes mellitus experience high rates of influenza virus infection and complications. We compared the magnitude and duration of serologic response to trivalent influenza vaccine in adults aged 50-80 with and without type 2 diabetes mellitus. Serologic response to influenza vaccination was similar in both groups: greater fold-increases in antibody titer occurred among individuals with lower pre-vaccination antibody titers. Waning of antibody titers was not influenced by diabetes status.
Item Type: | Article |
---|---|
Date Deposited: | 28 Dec 2021 00:45 |
Last Modified: | 28 Dec 2021 00:45 |
URI: | https://oak.novartis.com/id/eprint/46559 |